rs5891777
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_017780.4(CHD7):c.2376+43_2376+48dupTGGACT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.776 in 1,550,796 control chromosomes in the GnomAD database, including 469,561 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.78 ( 45749 hom., cov: 0)
Exomes 𝑓: 0.78 ( 423812 hom. )
Consequence
CHD7
NM_017780.4 intron
NM_017780.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.541
Genes affected
CHD7 (HGNC:20626): (chromodomain helicase DNA binding protein 7) This gene encodes a protein that contains several helicase family domains. Mutations in this gene have been found in some patients with the CHARGE syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 8-60800567-A-ATGGACT is Benign according to our data. Variant chr8-60800567-A-ATGGACT is described in ClinVar as [Likely_benign]. Clinvar id is 260894.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.92 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.776 AC: 117300AN: 151208Hom.: 45725 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
117300
AN:
151208
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.801 AC: 166321AN: 207726 AF XY: 0.802 show subpopulations
GnomAD2 exomes
AF:
AC:
166321
AN:
207726
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.776 AC: 1085308AN: 1399472Hom.: 423812 Cov.: 25 AF XY: 0.778 AC XY: 537772AN XY: 691640 show subpopulations
GnomAD4 exome
AF:
AC:
1085308
AN:
1399472
Hom.:
Cov.:
25
AF XY:
AC XY:
537772
AN XY:
691640
Gnomad4 AFR exome
AF:
AC:
23041
AN:
31518
Gnomad4 AMR exome
AF:
AC:
31192
AN:
38066
Gnomad4 ASJ exome
AF:
AC:
17640
AN:
23354
Gnomad4 EAS exome
AF:
AC:
36662
AN:
38632
Gnomad4 SAS exome
AF:
AC:
66138
AN:
76578
Gnomad4 FIN exome
AF:
AC:
43021
AN:
51516
Gnomad4 NFE exome
AF:
AC:
818289
AN:
1076526
Gnomad4 Remaining exome
AF:
AC:
45248
AN:
57786
Heterozygous variant carriers
0
11117
22234
33352
44469
55586
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20116
40232
60348
80464
100580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.776 AC: 117374AN: 151324Hom.: 45749 Cov.: 0 AF XY: 0.784 AC XY: 57925AN XY: 73918 show subpopulations
GnomAD4 genome
AF:
AC:
117374
AN:
151324
Hom.:
Cov.:
0
AF XY:
AC XY:
57925
AN XY:
73918
Gnomad4 AFR
AF:
AC:
0.729047
AN:
0.729047
Gnomad4 AMR
AF:
AC:
0.805457
AN:
0.805457
Gnomad4 ASJ
AF:
AC:
0.746385
AN:
0.746385
Gnomad4 EAS
AF:
AC:
0.942562
AN:
0.942562
Gnomad4 SAS
AF:
AC:
0.87526
AN:
0.87526
Gnomad4 FIN
AF:
AC:
0.830568
AN:
0.830568
Gnomad4 NFE
AF:
AC:
0.772001
AN:
0.772001
Gnomad4 OTH
AF:
AC:
0.755714
AN:
0.755714
Heterozygous variant carriers
0
1321
2642
3964
5285
6606
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
860
1720
2580
3440
4300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
3129
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
CHARGE syndrome Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hypogonadotropic hypogonadism 5 with or without anosmia Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at